Traduction de «stimulation transcrânienne par courant continu » (Français → Anglais) :

transcranial direct current stimulation

– (PT) I voted for this report as I agree that the Commission should take responsibility for ensuring the monitoring and funding of projects in the following areas: new investment in research and the development and deployment of renewable energy, in energy efficiency, especially in the European building stock, as well as in resource-use efficiency more generally; strengthening the European energy network by interconnecting national networks and distributing power from major centres of renewable energy production to consumers, as well as introducing new forms of energy storage and the European High Voltage Direct Current (HVDC) ‘super-g ...[+++]rid’; promoting EU space-based infrastructures in the area of radio navigation and earth observation in order to foster the provision of new EU services and the development of innovative applications, as well as to facilitate implementation of EU legislation and policies; providing fast Internet access throughout the Union, ensuring the rapid execution of the EU’s digital agenda and providing all citizens with reliable, free access.

Maintain the EU’s coordinative role in the development of the EU policy on rare diseases and to support Member States in their activities on the national level. Continue to support the development of high quality National Rare Diseases Plans/Strategies in the European Union. Provide continued support for the International Rare Disease Research Consortium and initiatives developed under its umbrella. Continue to ensure proper codification of rare diseases. Work further to decrease inequalities between patients with rare diseases and pa ...[+++]tients suffering from more common disorders and to support initiatives promoting equal access to diagnosis and treatment. Continue to promote patients empowerment in all aspects of rare diseases policy development Continue activities increasing public awareness about rare diseases and EU activity in this field Make use of the Directive 2011/24/EU on the application of patients’ rights in cross-border healthcare to bring together European Reference Networks on rare diseases. Support the development of the tools facilitating cooperation and interoperability of the European Reference Networks for rare diseases. Stimulate development and use of eHealth solutions in the area of rare diseases. Implement and continue support for the European Platform on rare diseases registration. Continue playing a global role in the rare diseases initiative and collaborating with important international stakeholders.

Maintain the EU’s coordinative role in the development of the EU policy on rare diseases and to support Member States in their activities on the national level. Continue to support the development of high quality National Rare Diseases Plans/Strategies in the European Union. Provide continued support for the International Rare Disease Research Consortium and initiatives developed under its umbrella. Continue to ensure proper codification of rare diseases. Work further to decrease inequalities between patients with rare diseases and pa ...[+++]tients suffering from more common disorders and to support initiatives promoting equal access to diagnosis and treatment. Continue to promote patients empowerment in all aspects of rare diseases policy development Continue activities increasing public awareness about rare diseases and EU activity in this field Make use of the Directive 2011/24/EU on the application of patients’ rights in cross-border healthcare to bring together European Reference Networks on rare diseases. Support the development of the tools facilitating cooperation and interoperability of the European Reference Networks for rare diseases. Stimulate development and use of eHealth solutions in the area of rare diseases. Implement and continue support for the European Platform on rare diseases registration. Continue playing a global role in the rare diseases initiative and collaborating with important international stakeholders.

We must also improve Canada's competitiveness by making our regulatory systems more efficient, transparent, and predictable, by re-energizing the drive toward less inhibited interprovincial commerce; by bolstering the strength and the efficiency of Canadian capital markets; by maintaining Canada's competitive tax system; by continuing to invest in sustainable, high-quality public infrastructure; and by promoting trade and investment, including a determined fight for legitimate market access on behalf of Canadian producers of cattle and beef, softwood lumber, and wheat.